Interest of luspatercept in treatment of anemia in lower-risk of myelodysplastic syndrome anemia: a single center study of 26 patients. (PubMed, Blood Res) - Oct 8, 2026 - "Luspatercept appears to be effective in improving red blood cell production and reducing transfusion requirements in low-risk patients with MDS, with a favorable safety profile."
Journal • Review • Anemia • Fatigue • Hematological Disorders • Hematological Malignancies • Myelodysplastic Syndrome • Oncology • SF3B1
|
|
A Elalaoui; C Girault; T Cluzeau
|